Examination Report |
1 | TM-1 | 15 Jun 2012 |
10 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
11 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
12 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
13 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
14 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
15 | Journal Copy | 15 Feb 2018 |
2 | Reply to Exam Report (MIS-R) | 19 Sep 2013 |
3 | Evidence Affidavit Under Rule 45 (TOP) | 10 Nov 2017 |
4 | Evidence Affidavit Under Rule 46 (TOP) | 28 Nov 2017 |
5 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
6 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
7 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
8 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
9 | Evidence Affidavit Under Rule 47 (TOP) | 22 Dec 2017 |
1 | Hearing Notice (Show Cause) | 2416412 | 1262404 | 06 Oct 2015 |
2 | Tribunal Accepted Notice for : 2349037 | 2495284 | 1279370 | 03 Nov 2015 |
3 | Opposition Counter Statement | 5140661 | 2191490 | 21 Sep 2017 |
Trademark was applied on 15 June 2012 with IP India.
Proprietor of Telmiblok is EMCURE PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Telmiblok is Opposed.
Application number alloted to the trademark is 2349037.
Aditya & Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
DEVICE